Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by investclub


V.TLT

RE:RE:RE:Most Important Part of PR

winr88 wrote I believe Monday will be the news day investclub. Start the...

October 31, 2019

V.TLT

RE:Most Important Part of PR

Since it was filed Oct. 1st that would mean 30 days is midnight tonight. let&...

October 31, 2019

V.TLT

RE:RE:News Out

The company has commenced a phase 2 NMIBC clinical study to enroll and treat...

October 31, 2019

V.TLT

RE:RE:RE:Media

LaserStock29 wrote  That's a completely unacceptable signal to send...

October 31, 2019

V.TLT

Media

As promised I talked to Amelia this morning she did say they do talk to BNN...

October 31, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

Ok I just sent the email off to BNN .... see if I get a response. 

October 30, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

Ok LaserStock29 I really would also like to see a good piece of coverage on...

October 30, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

LaserStock29 wrote   Bottom line.. UHN and TLT 'CHOSE' 7...

October 30, 2019

V.TLT

RE:On the verge of exciting results

I also would like to Express my thanks to Eoganacht in educating us and for...

October 30, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

Good input Claridge thanks .... it just wouldn't make sense not to...

October 30, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

winr88 wrote Hi Investclub This makes the FDA application look good in my...

October 30, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

Hi StevenBirch  if Theralase hasn't any feedback from the FDA then...

October 30, 2019

V.TLT

RE:RE:RE:Why is TLT's valuation being suffocated?

Hey winr88 ... that was a fantastic article also explains the behavior of...

October 28, 2019

V.TLT

RE:RE:RE: Materials from Friday meeting

Gooseybear wrote Apparently so as I just received an email reply to my...

October 28, 2019

V.TLT

What happens between IND & 1st patient results?

Do we see the rest of Canadian sites announced and one patient per month...

October 27, 2019

V.TLT

RE:"...is currently working with the FDA..."

toade1313 wrote In the Oct 22nd PR it states.."The Company has...

October 27, 2019

V.TLT

RE:RE:RE:Any Information from the corporate presentation?

If we see anything it will probably come from Theralase on perhaps a video of...

October 26, 2019

V.TLT

RE:RE:RE:RE:RE:Once an IND is submitted, the FDA has 30 days to object

Longholder99 wrote   I've thought it would be the last few...

October 25, 2019

V.TLT

RE:RE:RE:Once an IND is submitted, the FDA has 30 days to object

Then as of next Friday Nov. 1st will be day 31 which is a day past the 30...

October 25, 2019

V.TLT

RE:INVITE LIST

@mackieresearch   @bloomburton   @BeaconSec  ...

October 25, 2019

Featured Company